 |
|
Effects of a Randomized Controlled Trial of Transcendental Meditation on Components of the Metabolic Syndrome in Subjects With Coronary Heart Disease
Maura Paul-Labrador, MPH;
Donna Polk, MD, MPH;
James H. Dwyer, PhD ;
Ivan Velasquez, MD;
Sanford Nidich, PhD;
Maxwell Rainforth, PhD;
Robert Schneider, MD;
C. Noel Bairey Merz, MD
Arch Intern Med. 2006;166:1218-1224.
Background The metabolic syndrome is thought to be a contributor to coronary heart disease (CHD), and components of the syndrome have been identified as possible therapeutic targets. Previous data implicate neurohumoral activation related to psychosocial stress as a contributor to the metabolic syndrome. The aim of this study was to evaluate the efficacy of transcendental meditation (TM) on components of the metabolic syndrome and CHD.
Methods We conducted a randomized, placebo-controlled clinical trial of 16 weeks of TM or active control treatment (health education), matched for frequency and time, at an academic medical center in a total of 103 subjects with stable CHD. Main outcome measures included blood pressure, lipoprotein profile, and insulin resistance determined by homeostasis model assessment (calculated as follows: [(fasting plasma glucose level [in milligrams per deciliter] x fasting plasma insulin level [in microunits per milliliter]) x 0.0552]/22.5); endothelial function measured by brachial artery reactivity testing; and cardiac autonomic system activity measured by heart rate variability.
Results The TM group had beneficial changes (measured as mean ± SD) in adjusted systolic blood pressure (–3.4 ± 2.0 vs 2.8 ± 2.1 mm Hg; P = .04), insulin resistance (–0.75 ± 2.04 vs 0.52 ± 2.84; P = .01), and heart rate variability (0.10 ± 0.17 vs –0.50 ± 0.17 high-frequency power; P = .07) compared with the health education group, respectively. There was no effect of brachial artery reactivity testing.
Conclusions Use of TM for 16 weeks in CHD patients improved blood pressure and insulin resistance components of the metabolic syndrome as well as cardiac autonomic nervous system tone compared with a control group receiving health education. These results suggest that TM may modulate the physiological response to stress and improve CHD risk factors, which may be a novel therapeutic target for the treatment of CHD.
Author Affiliations: Division of Cardiology, Department of Medicine, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center (Ms Paul-Labrador and Drs Polk, Velasquez, and Merz), and Department of Preventive Medicine, University of Southern California Keck School of Medicine (Dr Dwyer), Los Angeles; and the Institute for Natural Medicine and Prevention, Maharishi University of Management, Maharishi Vedic City, Iowa (Drs Nidich, Rainforth, and Schneider).
Deceased, October 26, 2005.
RELATED LETTERS
Transcendental Meditation and Components of the Metabolic Syndrome: Methodological Issues
Chittaranjan Andrade
Arch Intern Med. 2006;166(22):2553.
EXTRACT
| FULL TEXT
Why Meditate When You Could Just Rest?
Raj Dhwarka Persaud
Arch Intern Med. 2006;166(22):2553.
EXTRACT
| FULL TEXT
Why Meditate When You Could Just Rest?—Reply
Maura Paul-Labrador and C. Noel Bairey Merz
Arch Intern Med. 2006;166(22):2554.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Mind-body interventions: Applications in neurology
Wahbeh et al.
Neurology 2008;70:2321-2328.
ABSTRACT
| FULL TEXT
Transcendental Meditation and Components of the Metabolic Syndrome: Methodological Issues
Andrade
Arch Intern Med 2006;166:2553-2553.
FULL TEXT
Why Meditate When You Could Just Rest?--Reply
Paul-Labrador and Merz
Arch Intern Med 2006;166:2554-2554.
FULL TEXT
Why Meditate When You Could Just Rest?
Persaud
Arch Intern Med 2006;166:2553-2553.
FULL TEXT
|
